ReviewAmerican journal of preventive cardiology2023

Call to action: Understanding the differences in the use of SGLT-2 inhibitors and GLP-1 receptor agonists.

Apurva Khedagi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.